Epsilon Healthcare Limited
Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in two segments, Contract Development and Manufacturing Activities; and Telehealth Medical Practice Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturing of active pharmace… Read more
Epsilon Healthcare Limited (HDRPF) - Net Assets
Latest net assets as of December 2024: $15.11 Million USD
Based on the latest financial reports, Epsilon Healthcare Limited (HDRPF) has net assets worth $15.11 Million USD as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($22.26 Million) and total liabilities ($7.16 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $15.11 Million |
| % of Total Assets | 67.86% |
| Annual Growth Rate | 3.65% |
| 5-Year Change | -40.34% |
| 10-Year Change | N/A |
| Growth Volatility | 51.63 |
Epsilon Healthcare Limited - Net Assets Trend (2016–2024)
This chart illustrates how Epsilon Healthcare Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Epsilon Healthcare Limited (2016–2024)
The table below shows the annual net assets of Epsilon Healthcare Limited from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $15.11 Million | +100.36% |
| 2023-12-31 | $7.54 Million | -18.67% |
| 2022-12-31 | $9.27 Million | -52.63% |
| 2021-12-31 | $19.57 Million | -22.70% |
| 2020-12-31 | $25.32 Million | +13.43% |
| 2019-12-31 | $22.32 Million | -20.53% |
| 2018-12-31 | $28.09 Million | +31.51% |
| 2017-12-31 | $21.36 Million | +88.29% |
| 2016-12-31 | $11.34 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Epsilon Healthcare Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2869338800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $29.41 Million | 444.43% |
| Other Comprehensive Income | $8.97 Million | 135.62% |
| Total Equity | $6.62 Million | 100.00% |
Epsilon Healthcare Limited Competitors by Market Cap
The table below lists competitors of Epsilon Healthcare Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
IMPERIAL TOBACCO - Dusseldorf Stock Exchang
DU:ITB
|
$339.31K |
|
Inter Industries
TA:ININ
|
$339.38K |
|
SANDVIK (SVKB.SG)
STU:SVKB
|
$339.42K |
|
Rexel SA
BE:E7V
|
$339.49K |
|
MUEHLBAUER HOLDING - Dusseldorf Stock Exchang
DU:MUB
|
$338.92K |
|
OSAKA GAS - Dusseldorf Stock Exchang
DU:OSA
|
$338.86K |
|
GS Holdings Corp. Pfd. Series 1
KQ:078935
|
$338.81K |
|
NEURONES (NE9.SG)
STU:NE9
|
$338.68K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Epsilon Healthcare Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 7,539,223 to 6,616,844, a change of -922,379 (-12.2%).
- Net loss of 2,008,403 reduced equity.
- New share issuances of 720,000 increased equity.
- Other comprehensive income increased equity by 151,078.
- Other factors increased equity by 214,946.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-2.01 Million | -30.35% |
| Share Issuances | $720.00K | +10.88% |
| Other Comprehensive Income | $151.08K | +2.28% |
| Other Changes | $214.95K | +3.25% |
| Total Change | $- | -12.23% |
Book Value vs Market Value Analysis
This analysis compares Epsilon Healthcare Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.08x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | $0.24 | $0.00 | x |
| 2017-12-31 | $0.26 | $0.00 | x |
| 2018-12-31 | $0.23 | $0.00 | x |
| 2019-12-31 | $0.17 | $0.00 | x |
| 2020-12-31 | $0.16 | $0.00 | x |
| 2021-12-31 | $0.10 | $0.00 | x |
| 2022-12-31 | $0.05 | $0.00 | x |
| 2023-12-31 | $0.02 | $0.00 | x |
| 2024-12-31 | $0.02 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Epsilon Healthcare Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -30.35%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -35.86%
- • Asset Turnover: 0.25x
- • Equity Multiplier: 3.36x
- Recent ROE (-30.35%) is above the historical average (-41.53%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | -1.88% | 0.00% | 0.00x | 1.01x | $-1.35 Million |
| 2017 | -11.98% | -134.45% | 0.09x | 1.03x | $-4.69 Million |
| 2018 | -30.66% | -323.23% | 0.08x | 1.17x | $-11.42 Million |
| 2019 | -52.32% | -243.71% | 0.17x | 1.25x | $-13.91 Million |
| 2020 | -43.24% | -148.77% | 0.20x | 1.47x | $-13.48 Million |
| 2021 | -45.52% | -162.03% | 0.18x | 1.56x | $-10.87 Million |
| 2022 | -143.35% | -186.84% | 0.35x | 2.21x | $-14.22 Million |
| 2023 | -14.47% | -16.40% | 0.46x | 1.91x | $-1.84 Million |
| 2024 | -30.35% | -35.86% | 0.25x | 3.36x | $-2.67 Million |
Industry Comparison
This section compares Epsilon Healthcare Limited's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Epsilon Healthcare Limited (HDRPF) | $15.11 Million | -1.88% | 0.47x | $338.96K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |